KRT19 and hepatocellular carcinoma: The western blotting results showed that compared with CK19− cells, CK19+ HCC cells had increased phosphorylation of STAT3 at Tyr705, and STAT3 Tyr705 phosphorylation was decreased by regorafenib treatment in CK19+ cells (Fig. 7A).